Advances at Mass General Cancer Center: Recent Episodes
Advances at Mass General Cancer Center
This podcast is a companion to Mass General Cancer Center’s electronic publication, and both are centered around our investigators recent publications in high-profile journals. Each expert will give you insight into who they are and what inspires them to do what they do every day. A deeper dive into their research will better your understanding of where our experts’ ideas come from, where they will go from here, and what the future has in store in their particular field of research.
Drs. Shannon Stott and Brian Nahed explain why their new technology is an important breakthrough for glioblastoma patients, and share what’s next for their research.
Drs. Shannon Stott and Brian Nahed describe a new technique that uses microfluidics and engineered nanosurfaces to capture EVs released from glioblastoma multiforme, the most common and aggressive form of brain cancer.
In this episode, Drs. Shannon Stott and Brian Nahed explain their backgrounds and share how they met and began working with each other.
In this episode, Ethel Pereira and Tim Padera share why the protocol in this study isn’t safe to use for humans yet, and what the next steps will advance the research to improve patient care.
Tim Padera, PhD, and research fellow, Ethel Pereira, PhD, provide insight into their study of transit tumor cells.
Listen to hear how Tim Padera made his way from being an engineer in Chicago to becoming a cancer researcher in Boston.
In this episode we’ll hear about Ethel Pereira’s background and how she became interested in science, and specifically in cancer research.
Dr. David Miyamoto explains the impact of his research in prostate cancer, and mentions how it can potentially translate to bladder cancer.
Dr. David Miyamoto explains his study that examines new technology for treating prostate cancer.